Khalifa, Ahmad O.
Kavran, Michael
Mahran, Amr
Isali, Ilaha
Woda, Juliana
Flask, Chris A.
Penn, Marc S.
Hijaz, Adonis K.
Funding for this research was provided by:
Juventus Therapeutics, Inc.
Article History
Received: 12 September 2018
Accepted: 2 January 2019
First Online: 21 January 2019
Compliance with ethical standards
:
: Ahmad O. Khalifa: no conflict of interest; Michael Kavran: no conflict of interest; Amr Mahran: no conflict of interest; Ilaha Isali: no conflict of interest; Juliana Woda: former commercial developer of SDF-1 plasmid technology at Juventas Therapeutics; Chris A. Flask: no conflict of interest; Marc S. Penn: no conflict of interest; Adonis Hijaz: speaker for Astellas Pharma.